The FDA recently approved Casgevy, a gene-editing medical treatment which uses CRISPR/Cas9 technology to treat sickle cell disease. Casgevy, which two Stanford faculty members contributed to via drug development and FDA approval, is the first gene-editing medical treatment to recieve FDA approval.
Best Related Work Hugo | File 770 file770.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from file770.com Daily Mail and Mail on Sunday newspapers.
Getting a Next-Generation Genome Editing Therapy for Sickle Cell Disease Back on Track globalgenes.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from globalgenes.org Daily Mail and Mail on Sunday newspapers.
FDA Approves the First CRISPR Therapy for Sickle Cell Disease genengnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from genengnews.com Daily Mail and Mail on Sunday newspapers.
A Sickle Sequel: Matthew Porteus Launches Kamau with Positive Nula-Cell Patient Zero Results genengnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from genengnews.com Daily Mail and Mail on Sunday newspapers.